Is HeartSciences going out of business?

HeartSciences Inc. (HSCS) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

HeartSciences Inc. (HSCS) scores 11 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Shares dilution YoY: 174.40% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.

Five questions, kept separate

Survival - Fragile

Standard cash-runway arithmetic is not meaningful for this financial company; an active going-concern warning asserted on 2026-07-23 is the decisive Survival evidence.

Business quality - Evidence incomplete

Evidence incomplete financial Business Quality based on the bank evidence currently available.

Trajectory - Evidence incomplete

Comparable evidence covers 55% of this trajectory model. No comparable return on assets evidence.

Valuation - Extreme expectations

98.3x book value support an extreme expectations Valuation assessment for this financial company.

Event risk - Critical event risk

Going-Concern Warning is the decisive filing event; one adverse event family is active. Favorable events are shown separately and do not offset adverse risk.

What the rules read

• Shares dilution YoY: 174.40% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.
• ROE: -4044.00%
• Filing event risk: Going-Concern Warning (-8 pts)
• Revenue CAGR (3Y): -5.70%
• Net income trend: 15.55%
• Debt Maturity Runway: 0% long-term (Near-term refinancing risk)
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-08-20.

Price as of 2026-09-26.